Gault Cherylinsider trades

In SEC Form 4 filings, Gault Cheryl is listed as Chief Operating Officer of Rapport Therapeutics, Inc. (RAPP). In the last 90 days, Gault Cheryl sold $331.9K of Rapport Therapeutics, Inc. (RAPP) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
RAPPRapport Therapeutics, Inc.	Chief Operating Officer	2	Oct 1

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-01

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
RAPPRapport Therapeutics, Inc.	Sep 30	Oct 1	S	7,925	$33.04	Sale −$261,813	141,989	Yes	Form 4
RAPPRapport Therapeutics, Inc.	Sep 30	Oct 1	S	2,075	$33.76	Sale −$70,043	139,914	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.